西藏药业
(600211)
| 流通市值：132.12亿 | | | 总市值：132.12亿 |
| 流通股本：3.22亿 | | | 总股本：3.22亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,040,163,047.6 | 2,141,159,039.9 | 1,921,176,666.7 | 1,648,214,061.09 |
| 交易性金融资产 | 1,230,789,535.59 | 885,743,388.04 | 1,205,178,115.26 | 976,624,110.58 |
| 应收票据及应收账款 | 442,808,102.94 | 772,545,589.69 | 549,300,311.58 | 560,268,389.51 |
| 其中：应收票据 | 77,925,389.14 | 54,626,922.75 | 58,471,506.09 | 33,374,836.1 |
| 应收账款 | 364,882,713.8 | 717,918,666.94 | 490,828,805.49 | 526,893,553.41 |
| 应收款项融资 | 153,981,964.85 | 189,704,896.13 | 169,055,290.09 | 172,551,792.83 |
| 预付款项 | 24,053,507.6 | 20,146,217.12 | 18,519,514.25 | 11,428,619.1 |
| 其他应收款合计 | 18,279,337.31 | 11,867,856.51 | 12,444,957.5 | 11,848,498.12 |
| 存货 | 174,650,923.58 | 149,261,875.75 | 148,803,363.56 | 134,187,214.07 |
| 其他流动资产 | 60,797,750.09 | 51,501,968.88 | 40,650,831.5 | 54,785,547.86 |
| 流动资产合计 | 4,145,524,169.56 | 4,221,930,832.02 | 4,065,129,050.44 | 3,569,908,233.16 |
| 非流动资产: | | | | |
| 长期股权投资 | 379,978,194.91 | 380,217,679.97 | 85,817,729.28 | 86,558,123.28 |
| 其他权益工具投资 | 33,825,150 | 33,825,150 | 33,825,150 | 33,825,150 |
| 其他非流动金融资产 | 12,559,946.75 | 12,559,946.75 | 12,559,946.75 | 12,559,946.75 |
| 投资性房地产 | 25,311,950.17 | 25,732,978.74 | 26,154,007.29 | 26,575,035.86 |
| 固定资产 | 622,356,885.81 | 613,978,779.48 | 594,445,225.32 | 603,551,254.95 |
| 在建工程 | 39,758,037.64 | 37,661,308.16 | 66,134,726.67 | 65,060,676.43 |
| 使用权资产 | 562,644.42 | 789,791 | 1,015,942.5 | 1,241,814.78 |
| 无形资产 | 313,393,939.96 | 170,493,680.66 | 177,662,326.93 | 184,094,599.65 |
| 开发支出 | 1,334,182.28 | 1,334,182.28 | 1,334,182.28 | 1,334,182.28 |
| 商誉 | 91,289,419.5 | 8,876,674.01 | 8,876,674.01 | 8,876,674.01 |
| 长期待摊费用 | 2,745,864.58 | 1,059,867.45 | 1,175,682.3 | 1,292,322.18 |
| 递延所得税资产 | 144,195,014.99 | 148,479,706.24 | 145,260,705.62 | 151,049,219.46 |
| 其他非流动资产 | 3,491,114.8 | 6,224,179.34 | 2,811,261.16 | 1,411,108.34 |
| 非流动资产合计 | 1,670,802,345.81 | 1,441,233,924.08 | 1,157,073,560.11 | 1,177,430,107.97 |
| 资产总计 | 5,816,326,515.37 | 5,663,164,756.1 | 5,222,202,610.55 | 4,747,338,341.13 |
| 流动负债: | | | | |
| 短期借款 | 966,971,526.67 | 692,433,087.49 | 516,180,583.52 | 272,166,210.03 |
| 应付票据及应付账款 | 32,702,767.57 | 31,444,912.82 | 15,839,513.26 | 25,409,561.11 |
| 应付账款 | 32,702,767.57 | 31,444,912.82 | 15,839,513.26 | 25,409,561.11 |
| 预收款项 | 79,969.8 | 79,920 | 418,252.7 | 172,780.2 |
| 合同负债 | 5,667,046.75 | 1,579,849.98 | 5,453,386.36 | 4,908,971.89 |
| 应付职工薪酬 | 21,464,049.57 | 18,005,403.23 | 16,986,270.07 | 35,801,397.12 |
| 应交税费 | 45,751,188.28 | 129,511,737.57 | 53,483,551.19 | 49,850,613.59 |
| 其他应付款合计 | 298,927,950.01 | 563,388,766.74 | 442,909,235.15 | 376,702,742.19 |
| 一年内到期的非流动负债 | 411,116.42 | 587,978.21 | 911,317.86 | 920,921.5 |
| 其他流动负债 | 694,565.66 | 179,380.49 | 657,807.51 | 638,166.35 |
| 流动负债合计 | 1,372,670,180.73 | 1,437,211,036.53 | 1,052,839,917.62 | 766,571,363.98 |
| 非流动负债: | | | | |
| 租赁负债 | 185,629.34 | 223,387.9 | 128,206.52 | 302,372.71 |
| 长期应付款 | 431,613,096.85 | - | - | - |
| 递延收益 | 28,795,751.86 | 26,867,011.36 | 27,052,133.96 | 27,359,937.04 |
| 递延所得税负债 | 42,304,252.61 | 1,215,478.18 | 5,893,034.79 | 999,557.87 |
| 非流动负债合计 | 502,898,730.66 | 28,305,877.44 | 33,073,375.27 | 28,661,867.62 |
| 负债合计 | 1,875,568,911.39 | 1,465,516,913.97 | 1,085,913,292.89 | 795,233,231.6 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 322,319,196 | 322,319,196 | 322,319,196 | 322,319,196 |
| 资本公积 | 717,194,837.14 | 1,188,406,599.79 | 1,188,406,599.79 | 1,188,406,599.79 |
| 其他综合收益 | 63,680,342.01 | 72,628,065.96 | 75,949,123.11 | 77,566,005.21 |
| 盈余公积 | 163,009,955.49 | 163,009,955.49 | 163,009,955.49 | 163,009,955.49 |
| 未分配利润 | 2,285,232,771.57 | 2,414,741,890.7 | 2,351,347,515.73 | 2,166,514,777.22 |
| 归属于母公司股东权益合计 | 3,551,437,102.21 | 4,161,105,707.94 | 4,101,032,390.12 | 3,917,816,533.71 |
| 少数股东权益 | 389,320,501.77 | 36,542,134.19 | 35,256,927.54 | 34,288,575.82 |
| 股东权益合计 | 3,940,757,603.98 | 4,197,647,842.13 | 4,136,289,317.66 | 3,952,105,109.53 |
| 负债和股东权益合计 | 5,816,326,515.37 | 5,663,164,756.1 | 5,222,202,610.55 | 4,747,338,341.13 |
| 公告日期 | 2025-10-31 | 2025-08-16 | 2025-04-29 | 2025-03-15 |
| 审计意见(境内) | | | | 标准无保留意见 |